We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

CNS
6002
Digital Poster
Clinical
STUPP protocol and hypofractionated RT for glioblastoma in clinical practice
Garduno Sara, Spain
PO-1029
Homogeneous field radiotherapy in adults meduloblastoma. Report of four cases.
Imanol Paguey Garrido, Spain
PO-1030
Tumour volume influences local control and overall survival following Stereotactic Radiosurgery
Sophie Lynch, United Kingdom
PO-1031
Effects of SRS in patients affected with brain metastases from NSCLC: a single institution report
Ilaria Chiovatero, Italy
PO-1032
Molecular profile and early MRI changes after chemoradiation in high grade diffuse astrocytoma
Rimpa Basu Achari, India
PO-1033
Hypofractionated Radiotherapy and Simultaneous Boost in radically inoperable cases with Glioblastoma
Fabiana Gregucci, Italy
PO-1034
Re-Irradiation with high-dose stereotactic radiotherapy for recurrent High-grade Gliomas
Alia Mousli, Tunisia
PO-1035
Malignant
Yuuki takase, Japan
PO-1036
HYPOFRACTIONATED RADIATION THERAPY FOR NON-ELDERLY PATIENTS WITH GLIOBLASTOMA
Davide Tomasini, Italy
PO-1037
Radiotherapy with Temozolomide for Pediatric Glioblastoma:A single institute retrospective analysis.
Krishna Ratanchandani, India
PO-1038
Stereotactic radiotherapy with single-isocenter in multiple brain metastases
Paolo Matteucci, Italy
PO-1039
Brain metastasis recurrence for SRS in non-previously radiated patients
Alonso La Rosa de los Ríos, Spain
PO-1040
Skull base chordomas and chondrosarcomas: Trento Protontherapy Centre early experience
Marco Cianchetti, Italy
PO-1041
Dose-response-toxicity relationship to treatment in patients treated with Cerebral SBRT.
Laura Sonera Marcos, Spain
PO-1042
The influence of the conformity index of stereotactic radiotherapy for single brain metastasis
Kenji Makita, Japan
PO-1043
Stereotactic radiosurgery for meningioma: a single institution retrospective analysis
Orla Houlihan, United Kingdom
PO-1044
WHOLEBRAIN VS RADIOSURGERY/FRACTIONATED STEREOTACTIC RADIATIONTHERAPY: EXPERIENCE IN OUR CENTER.
Antonio Alayón Afonso, Spain
PO-1045
Multifraction stereotactic radiotherapy for brain metastases: initial experience.
Sofie Heylen, Belgium
PO-1046
Prospective evaluation of 167 brain metastases in Indian patients treated with robotic radiosurgery
Sruthi K, India
PO-1047
FluorEthyl-l-Tyrosine PET in glioma radiotherapy planning: an isotoxic dose prescription approach
Camilla Delli Paoli, Italy
PO-1048
Hypofractionated stereotactic reirradiation in patients with high-grade gliomas
Mercedes Lopez Gonzalez, Spain
PO-1049
11C-Methionine-PET scan for target delineation in patients treated with IMPT for CNS tumors.
SANTIAGO MARTIN PASTOR, Spain
PO-1050
Proton versus photon craniospinal irradiation in Pediatric patients with high-risk medulloblastoma
ALVARO LASSALETTA, Spain
PO-1051
Cyberknife stereotactic radiotherapy for vestibular schwannomas :a single institution experience
Hamza Ghassan, Belgium
PO-1052
Validation of Modified Combs criteria in Indian cohort for re-irradiation in recurrent gliomas
HARIDAS NAIR, India
PO-1053
Skull base meningiomas trated with Radiosurgery/Fractionated Stereotactic Radiotherapy
Maitane Rodriguez, Spain
PO-1054
Fractionated stereotactic radiotherapy in optic nerve meningioma
Lucía Paisán , Spain
PO-1055
The use of Auto-Segmentation tools to assess the SUV-isocontour in FET-PET to GTV delineation
Ahmed Gawish, Germany
PO-1056
Stereotactic radiosurgery of postoperative resection cavity for brain metastases
Fausto Sousa, Portugal
PO-1057
Should we include surgical tracts and scars in the CTV of High-grade gliomas?
Olalla Santa Cruz, Switzerland
PO-1058
LINAC-based radiosurgery for brain metastasis: patterns of recurrence and predictors of response
Bárbara Castro, Portugal
PO-1059
Cranial radiotherapy as salvage treatment in relapsed primary CNS lymphomas
Matthew Volpini, Canada
PO-1060
Acute relative lymphopenia is associated with poor survival in GBM following postoperative chemo-RT
Stefano Arcangeli, Italy
PO-1061
Stereotactic Radiosurgery for Brain Metastases from Renal Cell Carcinoma: A retrospective study
Guhan Rangaswamy, Ireland
PO-1062
Multicenter study for breast cancer brain metastasis: Role of whole-brain radiotherapy (KROG 1612)
Jae Sik Kim, Korea Republic of
PO-1063
Corneal and hippocampal dose in brain radiosurgery related with location: A phantom dosimetric study
Shikha Goyal, India
PO-1064
Overall survival of patients treated with repeated courses of stereotactic radiation therapy
Laure Kuntz, France
PO-1065
Quality and efficiency of automated organ at risk delineation on MRI in the brain
Jeroen Crouzen, The Netherlands
PO-1066
Exploratory analysis of serial 18F-Fluciclovine PET and mpMRI during chemoradiation for glioblastoma
Kavi Fatania, United Kingdom
PO-1067
SRS in brain metastases from breast cancer: a single-centre retrospective study
Rosario Ching-Lopez, Spain
PO-1068
Multiple Brain Metastases concomitantly treated with robotic SRS/SRT
Ariadna Sanchez Galvan, Italy
PO-1069
The potential implications of proton planning technique for LET-related changes on MRI
Alejandro Bertolet, USA
PO-1070
Hypofractionated stereotactic radiotherapy of brain metastases: a retrospective analysis.
Lupattelli Marco, Italy
PO-1071
FSR for arterio-venous malformations: a single-centre retrospective study.
Rosario Ching-Lopez, Spain
PO-1072
Feasibility of the APRICOT-trial: identifying MRI biomarkers for radiation-induced cognitive changes
Eva van Grinsven, The Netherlands
PO-1073